copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) - Childrens Hospital of . . . Opsoclonus-myoclonus-ataxia syndrome (often referred to as OMAS or opsoclonus-myoclonus syndrome) is an autoimmune disorder of the nervous system characterized by new movements of the limbs and eyes, abnormal behaviors, sleep dysregulation, and difficulty talking
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in . . . Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare disorder of the nervous system that classically presents with a combination of characteristic eye movement disorder and myoclonus, in addition to ataxia, irritability, and sleep disturbance
Opsoclonus myoclonus syndrome - Wikipedia Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous system It is an extremely rare condition, affecting as few as 1 in 10,000,000 people per year
Opsoclonus-myoclonus-ataxia syndrome - UpToDate Opsoclonus-myoclonus-ataxia syndrome (OMAS), also known as opsoclonus-myoclonus, is a rare and debilitating acquired nervous system disorder characterized by opsoclonus, diffuse or focal body myoclonus, and truncal titubation with or without ataxia and other cerebellar signs
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome Objectives and methods: Opsoclonus myoclonus ataxia syndrome (OMAS) is a rare neuroinflammatory disorder We aimed to retrospectively evaluate clinical and laboratory data and outcomes of 23 children diagnosed with OMAS in two children's hospitals between 2010 and 2021
An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome . . . Opsoclonus-myoclonus ataxia syndrome (OMAS) is a rare neu-roimmunological disorder that affects one in 5 million children per year,1 typically presenting in the second year of life with chaotic eye movements (opsoclonus), muscle jerks (myoclonus), impaired motor coordination (ataxia), and irritability 2 Although previous studies suggest that
Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients Opsoclonus-myoclonus ataxia syndrome (OMAS), also known as Kinsbourne syndrome, is a rare disorder that presents with myoclonus, ataxia, abnormal eye movements, irritability, and sleep disruptions, often in young children